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OPEN
IMMEDIATE COMMUNICATION
Genome-wide association study of alcohol consumption and
genetic overlap with other health-related traits in UK Biobank
(N= 112117)
T-K Clarke1, MJ Adams1, G Davies2, DM Howard1, LS Hall3, S Padmanabhan4, AD Murray5, BH Smith6, A Campbell7, C Hayward8,
DJ Porteous2,7, IJ Deary2,9 and AM McIntosh1,2
Alcohol consumption has been linked to over 200 diseases and is responsible for over 5% of the global disease burden. Well-known
genetic variants in alcohol metabolizing genes, for example, ALDH2 and ADH1B, are strongly associated with alcohol consumption
but have limited impact in European populations where they are found at low frequency. We performed a genome-wide
association study (GWAS) of self-reported alcohol consumption in 112 117 individuals in the UK Biobank (UKB) sample of white
British individuals. We report signiﬁcant genome-wide associations at 14 loci. These include single-nucleotide polymorphisms
(SNPs) in alcohol metabolizing genes (ADH1B/ADH1C/ADH5) and two loci in KLB, a gene recently associated with alcohol
consumption. We also identify SNPs at novel loci including GCKR, CADM2 and FAM69C. Gene-based analyses found signiﬁcant
associations with genes implicated in the neurobiology of substance use (DRD2, PDE4B). GCTA analyses found a signiﬁcant SNP-
based heritability of self-reported alcohol consumption of 13% (se = 0.01). Sex-speciﬁc analyses found largely overlapping GWAS
loci and the genetic correlation (rG) between male and female alcohol consumption was 0.90 (s.e. = 0.09, P-value =
7.16 × 10− 23). Using LD score regression, genetic overlap was found between alcohol consumption and years of schooling
(rG = 0.18, s.e. = 0.03), high-density lipoprotein cholesterol (rG = 0.28, s.e. = 0.05), smoking (rG = 0.40, s.e. = 0.06) and various
anthropometric traits (for example, overweight, rG =− 0.19, s.e. = 0.05). This study replicates the association between alcohol
consumption and alcohol metabolizing genes and KLB, and identiﬁes novel gene associations that should be the focus of future
studies investigating the neurobiology of alcohol consumption.
Molecular Psychiatry advance online publication, 25 July 2017; doi:10.1038/mp.2017.153
INTRODUCTION
In 2012, 5.9% of all global deaths were attributable to alcohol and
roughly a quarter of all deaths in the 20–39-year-age group.1 Over
200 diseases are linked to alcohol consumption and the
proportion of the global disease burden, measured in disability-
adjusted life years, is over 5%.1 Almost a quarter of disability-
adjusted life years attributable to alcohol consumption were the
result of neuropsychiatric disorders such as alcohol use disorders
(AUD) and major depressive disorder.2
There is a substantial genetic component to the variation in
alcohol consumption, although studies of alcohol use have largely
focused on AUD to date. A recent meta-analysis of twin and
adoption studies estimated the heritability of AUD to be 0.49 (95%
conﬁdence interval 0.43–0.53).3 A study of twin pairs with
genomic data estimated that the single-nucleotide polymorphism
(SNP)-based heritability of AUD was 33% (se = 0.12).4 Studies of
the heritability of alcohol consumption are far fewer in number, but
a study of 2877 twin pairs estimated the heritability of alcohol
consumption to be 0.43 (95% conﬁdence interval 0.31–0.56).
Using a sample of unrelated parents, the same authors estimated
~ 18% of the variance in alcohol consumption is attributable to
common SNPs.5
Speciﬁc genetic variants have been linked to variation in alcohol
consumption, the most inﬂuential being rs671 in the aldehyde
dehydrogenase (ALDH2) gene and a cluster of variants spanning
the alcohol dehydrogenase genes (ADH1B, ADH1C, ADH5, ADH6,
ADH7) located on chromosome 4q23. The catalytically inactive
version of ALDH2 encoded by the A allele of rs671 leads to slower
metabolism of acetaldehyde that causes the alcohol ﬂush reaction.
This reaction causes alcohol to be aversive for the A carriers of
rs671.6,7 As such, this polymorphism is highly protective against
alcoholism in Asian populations,8 although it has limited impact
in European and African populations where it is often
monomorphic.9 The rs1229984 in ADH1B is also associated with
an alcohol-ﬂush reaction in Asian populations and thus protects
against high alcohol consumption.10 It is also found to associate
with drinking pattern phenotypes in European and African
populations where the minor allele frequency (MAF) is
~ 1–4%.9,11,12 Common SNPs in ADH7 have been associated with
alcohol consumption in an Australian cohort of twins.13
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Genome-wide association studies (GWASs) of alcohol consump-
tion have found few consistently replicable loci outside of the
alcohol metabolizing genes. A GWAS of alcohol consumption
comprising 47 501 individuals of European ancestry found
rs6943555 in AUTS2 to be associated with alcohol
consumption.14 This locus did not replicate in a more recent
GWAS of alcohol consumption in4105 000 European individuals.
However, a SNP in KLB was associated with alcohol consumption
in humans and the gene product, β-klotho, was found to regulate
alcohol preference in mice.15
Alcohol consumption has been linked to psychiatric disorders
and other health-related traits, although this has generally been
limited to epidemiological observations16,17 or by assessing
genetic overlap using twin studies.18,19 Levels of alcohol
consumption within a population are strongly linked to cardio-
vascular disease, liver cirrhosis and cancer.17 Furthermore, twin
studies have shown that genetic factors overlap with alcoholism
and depression,20 attention-deﬁcit/hyperactivity disorder and
externalizing disorders.18 Studies that have assessed the SNP-
based genetic overlap between alcohol consumption and other
traits have been limited to other substance abuse phenotypes.
They have found that the polygenic architecture underlying
alcohol consumption is shared with tobacco, caffeine and
cannabis use.21,22
In the present study we perform the largest GWAS of self-
reported alcohol consumption in 112 117 individuals of European
ancestry from the UK Biobank (UKB). We also estimate the SNP-
based heritability of alcohol consumption and perform sex-
speciﬁc analyses to investigate whether the phenotypic differ-
ences in alcohol consumption in males and females have a
genetic basis. Furthermore, as alcohol consumption is often
associated with psychiatric and other diseases and health-related
traits, we examined the genetic overlap between alcohol
consumption and over 200 disease and behavioural traits. Using
a polygenic risk score (PRS) approach we also analysed the
amount of variance in self-reported alcohol consumption in a
completely independent sample, Generation Scotland: the
Scottish Family Health Study (GS) (N= 19 858).
MATERIALS AND METHODS
Samples
UK Biobank. UKB is a population-based sample comprising
502 629 individuals resident in the United Kingdom between the
age of 40 and 69 years.23 During the recruitment period from 2006
to 2010, individuals were recruited from 22 centres across the
United Kingdom to reﬂect a broad socioeconomic demographic
and mixture of urban and rural residents. During a self-completed
touchscreen interview taken at baseline appointment, participants
were asked about their current drinking status (never, previous,
current, prefer not to say) and were asked to report their average
weekly and monthly alcohol consumption of a range of drink
types (red wine, white wine, champagne, spirits, beer/cider,
fortiﬁed wine). These questions were accompanied by pictures
providing an example of a single measure of each drink type.
From these measures we derived an average intake of alcohol
consumption in units per week. We excluded all former drinkers
from the analysis and this left 112 117 individuals with data on
both alcohol consumption and genome-wide genotype data. We
also repeated our analyses with never drinkers excluded
(N= 108 309) and found the GWAS results to be consistent with
the GWAS of the full sample.
Generation Scotland: the Scottish family health study. GS is a
family- and population-based study comprising 24 096 individuals
aged between 18 and 99 years.24,25 Genome-wide genotype data
are available for 19 858 individuals.26 Alcohol consumption was
assessed using a preclinical questionnaire. Participants self-
identiﬁed as current drinkers, former drinkers or never drinkers.
Average consumption was self‐reported units of alcohol con-
sumed in the previous week and these questions were prompted
by a table containing the average units contained in a single
measure of various drink types to assist participants in the
calculation of weekly intake. Any GS individuals or relatives of GS
individuals were removed from the UKB sample before GWAS
analysis.
This study obtained informed consent from all participants and
was conducted under generic approval from the National Health
Service National Research Ethics Service (approval letter dated 17
June 2011, Ref 11/NW/0382) and under UK Biobank approval
4844 ‘Stratifying Resilience and Depression Longitudinally’ (prin-
cipal investigator AMM). All components of GS have received
ethical approval from the National Health Service Tayside
Committee on Medical Research Ethics (REC Reference Number:
05/S1401/89) and written consent for the use of data was
obtained from all participants.
Genotyping and imputation
UK Biobank. The majority of the UKB sample was genotyped
using the Affymetrix UK Biobank Axiom array (67%) (Santa Clara,
CA, USA) with the rest of the sample genotyped using the
Affymetrix UK BiLEVE Axiom array. Quality control, phasing and
imputation are described in detail elsewhere (http://biobank.ctsu.
ox.ac.uk/crystal/refer.cgi?id = 155583), (http://biobank.ctsu.ox.ac.
uk/crystal/refer.cgi?id = 155580), (http://biobank.ctsu.ox.ac.uk/crys
tal/refer.cgi?id = 157020). Brieﬂy, phasing was performed using a
modiﬁed version of the SHAPEIT2 algorithm27 with a combined
panel of the UK10K and 1000 Genomes phase 3 reference panels
used for imputation.28
Individuals were removed from the present study based on
non-British ancestry (within those who self-identiﬁed as being
British, principal component analysis was used to remove outliers,
n= 32 484), high missingness (n= 0), relatedness (n= 7948), quality
control failure in UK BiLEVE (n= 187) and gender mismatch (n= 0).
Relatedness was deﬁned as having a KING-estimated kinship
coefﬁcient of40.0442. For the GWAS analysis we used hard-called
genotypes with an imputation info score ⩾ 0.9, MAF ⩾ 0.1% and
Hardy–Weinberg equilibrium (HWE) P-value ⩽ 1 × 10− 6 (no. of
SNPs = 12 489 782). SNPs were then ﬁltered to only include those
where 480% of the sample had a hard-called genotype.
Generation Scotland. GS samples were genotyped using the
Illumina Human OmniExpressExome-8v1.0 Bead Chip and Inﬁnum
chemistry and processed using the Illumina Genome Studio
Analysis software v2011 (Illumina, San Diego, CA, USA). Quality
control was performed to remove SNPs with o98% call rate,
individuals with a genotyping rate o98% and SNPs with a HWE
P-value ⩽ 1 × 10− 6 and a MAF ⩾ 1%. This left 561 125 SNPs
available for analyses. More details on blood collection and DNA
extraction are provided elsewhere.25
Genome-wide association analyses
In the UKB, quality control was performed on the alcohol
consumption phenotype to remove extreme values. Weekly intake
values of 45 s.d. from the mean were set to missing. For males
this was for values4102 units per week and for females for values
489 units per week. Alcohol consumption was then log (units+1)
transformed and, as the mean alcohol intake in males was
signiﬁcantly higher than in females, we regressed age and weight
in kg onto weekly units of alcohol consumed in males and females
separately. We then took the residuals from these regressions and
pooled the male and female residuals together to create the
alcohol consumption phenotype. A male-only and female-only
GWAS was also performed.
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GWAS was performed using PLINK v1.9 (ref. 29) testing for
associations between SNPs and alcohol consumption in unrelated
individuals with location of UKB assessment centre, genotyping
batch and 15 principal components included as covariates. In
order to distinguish independent GWAS signals, SNPs with an
association P-value ⩽ 1 × 10− 4 were subjected to linkage
disequilibrium (LD)-based clumping that was performed in
PLINK,29 using an LD r2 cutoff of 0.2 and a 500 kb sliding window.
Conditional SNP analyses were performed using PLINK for the 8
SNPs on chromosome 4q found to be associated with alcohol
consumption. Each SNP was retested for association using the
same method as described for the GWAS but using one of the
seven other SNPs as a covariate. Conditional SNP analyses were
also performed in GCTA using a stepwise model selection pro-
cedure to conﬁrm which SNPs were independently associated.30,31
Heritability and genetic correlation analyses
Univariate GCTA-GREML analyses were performed to estimate the
SNP-based heritability of alcohol consumption in the whole UKB
sample and then for males and females separately. A genetic
relationship matrix was created for an unrelated subsample using
a cutoff of 0.025 (N= 89 175) and used to estimate heritability.31–33
The genetic correlation between male and female alcohol
consumption was estimated using LD score regression following
the pipeline designed by Bulik-Sullivan et al.34 This method
exploits the correlational structure of SNPs across the genome and
uses test statistics provided from GWAS summary estimates to
calculate the genetic correlations between traits.35 False discovery
rate was used to correct P-values for multiple testing. We supplied
the GWAS summary statistics from the GWAS of male and female
alcohol consumption. Using our GWAS summary statistics, the
genetic overlap between alcohol consumption and over 200 other
disease traits was assessed using LD score regression34 imple-
mented in the online software LD Hub (http://ldsc.broadinstitute.
org/).36
PRS analyses
PRSs were created in GS using raw genotype data using the
software PRsice37 using the GWAS summary statistics from the
UKB GWAS of alcohol consumption. PRSs were created using
P-value thresholds ranging from 0.01 to 0.5 in increments of 0.01
using LD pruning parameters of r2 = 0.1 over 250 kb windows. The
PRS P-value threshold found to explain most of the variance in
alcohol consumption in GS was at 0.42 and hence this PRS was
used to test for association in subsequent analyses. Association
between alcohol PRS and traits of interest was performed in
AS-Reml-R and an inverse relationship matrix created from the
pedigree information in GS was used to control for relatedness in
the sample. Four principal components were ﬁt as ﬁxed-effect
covariates to control for population stratiﬁcation. All traits and PRS
were scaled to have a mean of 0 and a s.d. of 1 such that the βs
reported are standardized. The variance explained by PRS was
calculated by multiplying the PRS by its regression coefﬁcient. This
value was divided by the variance of the phenotype analysed to
give a coefﬁcient of determination between 0 and 1.38 As 5 traits
were tested for their association with alcohol consumption PRS,
Bonferroni correction for PRS analyses required a P-value of 0.01
(0.05/5) as the threshold for statistical signiﬁcance.
The eQTLs and gene-based analyses
SNPs that were signiﬁcantly associated with alcohol consumption
(Po5 × 10− 8) in the GWAS were assessed to determine whether
they were potential expression quantitative trait loci (eQTLs) using
the Genotype Tissue Expression Portal (GTEx) (http://www.
gtexportal.org). GTEx uses gene expression data from multiple
human tissues linked to genotype data to provide information on
eQTLs. Gene-based analyses were performed using MAGMA,39
derived from SNP summary data from the GWAS of alcohol
consumption in this sample. The 1000 genomes European
reference panel (phase 1, release 3) was used to account for LD
in the sample. SNPs were mapped to genes using the NCBI 37.3
gene locations and Entrez gene IDs. This resulted in 18 024 genes
available for analysis that, after Bonferroni correction (0.05-
/18 024), gave a threshold for statistical signiﬁcance at 2.8 × 10− 6.
RESULTS
The mean self-reported alcohol consumption in the 112 117 UKB
individuals who contributed to the analysis in the present study
was 15.13 units per week (s.d. = 16.56). The mean age of
participants was 59.6 (s.d. = 7.95). The sample comprised 59 088
females (52.7%). Females had a signiﬁcantly lower mean weekly
alcohol intake compared with males (10.03 (s.d. = 11.83) vs 20.81
(s.d. = 19.04) units per week), P⩽ 2 × 10− 16.
The SNP-based heritability of alcohol consumption in the total
sample was estimated to be 0.13 (s.e. = 0.006, P= 1.3 × 10− 119). The
SNP heritability in males was estimated to be 0.15 (s.e. = 0.01,
P= 2.3 × 10− 41) and in females 0.13 (s.e. = 0.01, P= 8.1 × 10− 36).
The SNP heritability in males was not signiﬁcantly higher than in
females (Z-score = 1.43, P-value = 0.152). The SNP-based genetic
correlation between male and female alcohol consumption using
LD score regression was 0.9 (s.e. = 0.09, P-value = 7.16 × 10− 23),
suggesting that the genetic factors inﬂuencing alcohol consump-
tion in males and females in this sample were largely, but not
completely, overlapping.
The genome-wide association statistics deviated slightly from
the null (λGC = 1.092) (Supplementary Figure 1), though the LD
score regression intercept of 1.001 suggested that the inﬂation of
the test statistic was due to polygenicity rather than any
population stratiﬁcation.35 Genome-wide signiﬁcant associations
(Po5 × 10− 8) were obtained for 14 loci after clump-based
pruning (Table 1 and Figure 1). These included 8 hits on
chromosome 4q23/4q22.3 that span ~ 2.3 MB and several alcohol
dehydrogenase genes (ADH1B, ADH1C, ADH5) that have all
previously been implicated in alcohol consumption.9,12 Condi-
tional SNP GWAS of the variants on chromosome 4q suggests that
there are 4 independent hits in this region: rs145452708 in the
ADH1B/ADH1C region, rs29001570 in ADH5, rs35081954 in ADH1C
and rs193099203 that lies in an intergenic region of 4q23. Most of
the associated variants on 4q23 are relatively rate (MAF 0.006–
0.01) with the minor allele associated with lower alcohol
consumption. However, rs35081954 is a common insertion/
deletion polymorphism with a MAF of 0.42. Two hits were
identiﬁed on chromosome 4p14 in the KLB gene that was
previously associated with alcohol consumption in a large GWAS
of 4105 000 Europeans.15 Conditional SNP analyses suggested
these two SNPs were not completely independent and identiﬁed
rs11940694 as the lead SNP associated with alcohol consumption
(Supplementary Table 1). Novel hits included a SNP on chromo-
some 2p23.3 in the GCKR gene. The SNPs in KLB and GCKR were
the most strongly associated common (MAF 45%) SNPs with
MAFs of 40.28. Regional association plots for the common SNPs
in KLB and GCKR are shown in Figure 2. Additional novel hits on
chromosome 3p12.1 (CADM2) and chromosome 18q22.3 (FAM69C)
were also identiﬁed (Table 1). Two SNPs in CADM2 were associated
at genome-wide signiﬁcance level but conditional SNP analyses
found rs9841829 to be the lead SNP in this region. These loci will
be reviewed in greater detail in the discussion. Regional
association plots for all SNPs presented in Table 1 are shown in
Supplementary Figures 2.
A GWAS of alcohol consumption was performed excluding
individuals who were identiﬁed as never drinkers. The genetic
regions associated with alcohol consumption in current drinkers
overlapped with those reported in the total sample with the
exception of rs8012947 in the AT-rich interactive domain 4A
(ARID4A) gene on chromosome 14 (Supplementary Table 2 and
Supplementary Figure 11).
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Sex-speciﬁc GWASs of alcohol consumption were also per-
formed (Supplementary Figures 12 and 13). Only one novel locus
(rs140089781) was identiﬁed in males on chromosome 2 in
catenin-α2 (CTNNA2). rs140089781 was not analysed in females
because of the low MAF of this SNP (MAF o0.001). All other loci
identiﬁed in males or females had previously been identiﬁed at
the level of genome-wide signiﬁcance in the total sample
(Supplementary Table 3).
The gene-based analyses found 41 genes to be signiﬁcantly
associated with alcohol consumption (Supplementary Table 4).
The top hits were genes identiﬁed in the single SNP analyses
(KLB, CADM2, GCKR) and genes in the 4q region were also found to
be signiﬁcantly associated with alcohol consumption at the gene
level (ADH1C, C4orf17). Among the 41 loci associated at the gene
level, genes of interest include the dopamine receptor D2 (DRD2)
gene, previously associated with addiction phenotypes,40 chro-
modomain Y-like (CDYL) protein previously associated with alcohol
consumption, cAMP-speciﬁc 3′,5′-cyclic phosphodiesterase 4B
(PDE4B) associated with alcohol preference in rodents,41,42 zinc-
ﬁnger protein 512 (ZNF512) associated with oral cavity cancer43 and
protein phosphatase 1G (PPM1G) found to be hypermethylated in
individuals with AUD.44
Four SNPs located across KLB, CADM2 and GCKR were found to
be eQTLs according to the GTEx database (Supplementary Table
5). Notably, rs11940694 in KLB was found to be an expression QTL
for RCF1 and RPL9 in the cerebellum. rs9841829 in CADM2 is
associated with expression of CADM2 levels in lung and adipose
tissue.
The genetic correlations between alcohol consumption and 212
other health and behavioural traits were calculated using GWAS
summary statistics and LD score regression34 implemented in the
online software LD Hub.36 After correction for multiple testing, 11
traits had a signiﬁcant genetic correlation (Po0.05) with alcohol
consumption (Figure 3). Smoking status had the strongest positive
genetic correlation (rG) with alcohol consumption (rG = 0.40,
s.e. = 0.06, P= 1.4 × 10− 10) followed by high-density lipoprotein
(HDL) cholesterol levels (rG = 0.28, s.e. = 0.05, P= 6.9 × 10− 10).
Signiﬁcant negative genetic correlations were observed for
overweight (rG =− 0.19, s.e. = 0.05, P= 5.8 × 10− 5) and a range of
other anthropometric traits pertaining to body mass index (BMI)
and obesity, such as obesity class 2 (rG =− 0.20, s.e. = 0.06,
P= 3× 10− 4) that categorizes severely obese individuals with a
BMI ranging from 35.0 to 39.9 kg/m2.
Genetic correlations were also calculated using the sex-speciﬁc
GWAS summary statistics (Supplementary Figures 14 and 15). Male
Figure 1. Manhattan plot of genome-wide association study (GWAS) of alcohol consumption in UK Biobank (UKB; N= 112 177). Red line
indicates threshold for genome-wide signiﬁcance (P⩽ 5 × 10− 8) and the blue line for suggestive signiﬁcance (P⩽ 5× 10− 6).
Table 1. Fourteen loci reaching genome-wide signiﬁcance for association with alcohol consumption in UKB after performing clump-based LD
pruning
SNP CHR POS A1/A2 Freq β (s.e.) P Genes
rs145452708 4 100248642 C/G 0.01 − 0.034 (0.003) 1.15 × 10− 30 ADH1B/ADH1C
rs193099203 4 99630017 T/C 0.007 − 0.031 (0.003) 3.79 × 10− 25 —
rs1260326 2 27730940 T/C 0.39 − 0.028 (0.003) 1.34 × 10− 21 GCKR
rs11940694 4 39414993 A/G 0.39 − 0.027 (0.003) 8.4 × 10− 19 KLB
rs29001570 4 99994405 C/T 0.006 − 0.026 (0.003) 9.58 × 10− 19 ADH5
rs3114045 4 100252560 T/C 0.13 − 0.020 (0.003) 7.98 × 10− 12 ADH1B/ADH1C
rs140280172 4 100832564 A/C 0.005 − 0.020 (0.003) 2.89 × 10− 11 DNAJB14
rs9841829 3 85569361 G/T 0.23 0.019 (0.003) 3.36 × 10− 10 CADM2
rs35081954 4 100270818 CTG/C 0.42 0.018 (0.003) 2.14 × 10− 9 ADH1C
rs375507729 3 85062293 T/TAA 0.44 0.018 (0.003) 3.19 × 10− 9 CADM2
rs9991733 4 39420994 G/A 0.28 0.018 (0.003) 3.80 × 10− 9 KLB
rs149127347 4 99101007 G/T 0.003 − 0.018 (0.003) 4.42 × 10− 9 —
rs145329623 4 98528709 G/A 0.003 − 0.017 (0.003) 5.68 × 10− 9 STPG2
18:72124965 18 72124965 CCTCCCG/C 0.05 0.017 (0.003) 2.18 × 10− 8 FAM69C
Abbreviations: CHR, chromosome; Freq, A1 frequency; GWAS, genome-wide association study; LD, linkage disequilibrium; POS, base pair position; SNP, single-
nucleotide polymorphism; UKB, UK Biobank. Genes are reported if SNPs located ± 10 kb of the locus. SNPs highlighted as bold represent completely
independent associations identiﬁed by conditional SNP analyses.
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alcohol consumption showed a negative genetic correlation with
childhood height (rG =− 0.23, s.e. = 0.07, P= 0.002), childhood
obesity (rG =− 0.26, s.e. = 0.08, P= 0.001) and infant head circum-
ference (rG =− 0.34, s.e. = 0.11, P= 0.002). Female alcohol con-
sumption was genetically correlated with college completion
(rG = 0.3, s.e. = 0.06, P= 1.4 × 10− 7), height (rG = 0.18, s.e. = 0.04,
P= 2.4 × 10− 5) and bipolar disorder (rG = 0.22, s.e. = 0.08,
P= 0.005). Several metabolic traits were found to have negative
genetic correlations with female alcohol consumption including
low-density lipoprotein cholesterol (rG =− 0.23, s.e. = 0.07,
P= 9× 10− 4) and leptin (rG =− 0.41, s.e. = 0.11, P= 3× 10− 4).
Using the UKB GWAS summary statistics PRS for alcohol
consumption were calculated in GS to determine the amount of
variance that could be explained using a risk-score approach. PRSs
for alcohol consumption in GS were found to be positively
associated with alcohol consumption (β= 0.08, P= 6.5 × 10− 24) but
only 0.6% of the variance in alcohol consumption was explained
(Table 2). PRSs were also tested for association with traits found to
have a signiﬁcant genetic correlation with alcohol consumption in
the LD score regression analyses. BMI, weight, hip circumference,
smoking status and HDL cholesterol levels were all available in the
GS cohort. Signiﬁcant associations between alcohol PRS and
Figure 2. Linkage disequilibrium (LD) zoom plots of 2 common single-nucleotide polymorphisms (SNPs; minor allele frequency (MAF) 45%)
most signiﬁcantly associated (Po5× 10− 8) with alcohol consumption in UK Biobank. (a) The rs2872821 on chromosome 4 in KLB and (b)
rs1260326 on chromosome 2 located in GKCR (http://locuszoom.sph.umich.edu/).
Figure 3. Genetic correlation between Alcohol Consumption in UK Biobank (UKB) and other traits using linkage disequilibrium (LD) score
regression implemented in LD Hub. All traits presented pass false discovery rate (FDR) correction for multiple testing. HDL, high-density
lipoprotein.
GWAS alcohol consumption
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smoking were detected after adjustment for multiple testing
(β=− 0.143, P= 0.01), and with HDL cholesterol (β= 0.03,
P= 4.3 × 10− 5) and BMI (β= 0.02, P= 0.0013) (Table 2). No
signiﬁcant associations were found between PRSs and hip
circumference.
DISCUSSION
In the present study we identify eight independent loci associated
with alcohol consumption. Four of these loci are located among a
cluster of alcohol metabolism genes on chromosome 4q23
(ADH1B/ADH1C and ADH5) and have been previously identiﬁed
as risk loci for alcohol-related phenotypes.9,12 A SNP in KLB was
also associated with alcohol consumption and this locus has
previously been identiﬁed in a large meta-analysis of alcohol
consumption in Europeans.15 The remaining three hits are novel
loci (GCKR, CADM2 and FAM69C) in the context of alcohol
consumption and as such this study presents a novel contribution
to the genetics of alcohol consumption.
Identifying the causal variants located on 4q23 will prove to be
challenging because of the low MAF of the variants associated
with alcohol consumption in this region. Previous studies have
shown that rs1229984 in ADH1B, which is associated with rapid
alcohol metabolism, is strongly protective against high alcohol
consumption.10 It is possible that the low-frequency variants
identiﬁed in 4q23 are tagging rs1229984. However, rs1229984
deviated from HWE in the UKB (HWE P= 1.5 × 10− 78) and therefore
was not analysed as part of the GWAS. The rs29001570 in ADH5
clearly represents an independent locus as the r2 with the other
SNPs in 4q23 is o0.01. We believe this is the ﬁrst GWAS of alcohol
consumption to detect genome-wide signiﬁcant association with
ADH5, although a GWAS of alcohol dependence found suggestive
evidence of association with PDLIM5 that is adjacent to ADH5.12
ADH5 is a formaldehyde dehydrogenase with low afﬁnity for
alcohol and therefore its role in alcohol metabolism and
consumption is as yet unknown. rs145452708 that is located in
the region between ADH1B/ADH1C and rs35081954 is a common
variant located in intron 1 of ADH1C. ADH1B and ADH1C are
alcohol dehydrogenases expressed in the liver and are primarily
responsible for the catabolism of ethanol. Variants in ADH1B and
ADH1C have previously been associated with various alcohol
consumption phenotypes.9,12,45
The gene encoding β-Klotho (KLB) has recently been associated
with alcohol consumption in a large meta-analysis of 4105 000
Europeans. Schumann et al.15 found that brain-speciﬁc klb-
knockout mice have increased alcohol preference. They also
found that β-Klotho is a receptor for the liver-expressed hormone
FGF21 that acts on the brain and inhibits alcohol consumption in
mice. We are not aware of any sample overlap between UKB and
the sample used in the study by Schumann et al.15. GS individuals
were present in the GWAS reported by Schumann et al.15 but GS
individuals identiﬁed in the UKB sample were removed before
GWAS analysis. The study by Schumann et al.15 identiﬁed
rs11940694 to be associated with alcohol consumption and this
is the same SNP we report as associated in this sample. We
therefore provide evidence of replication of the association of this
variant with alcohol consumption. An additional SNP (rs9991733)
in KLB was associated with alcohol consumption in UKB; however,
the minor allele of this SNP conferred risk for high consumption
rather than protection. This SNP is in low LD with rs11940694
(r2 = 0.21, D’= 0.87); however, conditional SNP analyses showed
that these associations were not completely independent.
Novel loci found to be associated with alcohol consumption in
this study include GCKR, CADM2 and FAM69C. GCKR encodes the
glucokinase regulatory protein that is produced by hepatocytes
and is responsible for phosphorylation of glucose in the liver.
rs1260326 in GCKR is a coding missense SNP and this variant has
been associated with over 25 metabolic traits including type II
diabetes, fasting insulin levels and total cholesterol levels.46
CADM2 is a brain expressed gene encoding cell adhesion molecule
2 that has previously been associated with processing speed and
educational attainment in the UKB sample and processing speed
in the CHARGE consortium cohort.47,48 A recent study of
reproductive success and risk-taking propensity also found
genome-wide signiﬁcant associations with SNPs in CADM2.49
CADM2 has also been associated with lifetime cannabis use in a
GWAS of ~ 32 000 individuals.50
Several additional genes associated with alcohol consumption
were identiﬁed through MAGMA gene-based analyses, including
the gene CDYL. CDYL was also associated with alcohol consump-
tion at the gene level and a SNP in this gene has previously shown
some association with alcohol consumption in a GWAS of 47 501
Europeans.14 PDE4B was associated at the gene level and encodes
a protein that regulates alcohol-induced neuroinﬂammation in the
central nervous system.51 Animal models have shown that
inhibition of PDE4B leads to reduced alcohol intake in both mice
and rats.41,42 A GWAS found ZNF512 to be associated with oral
cavity cancer.43 The gene-based analysis in the present study
found this gene to be associated with alcohol consumption. This is
notable considering that alcohol consumption is a leading cause
of oral cavity cancer, suggesting that the link between ZNF512 and
alcohol consumption may underlie its association with oral cancer.
Using LD score regression, a signiﬁcant positive genetic
correlation between alcohol consumption and smoking was
identiﬁed. The overlap between alcohol consumption and
smoking is well documented and other studies have shown
polygenic overlap between weekly alcohol intake and the number
of cigarettes smoked (rG = 0.44).21 A positive genetic correlation
between HDL cholesterol and alcohol consumption was also
found. Increased alcohol consumption is associated with increased
HDL levels52 and a Mendelian randomization study of alcohol
consumption and lipid proﬁles found a causal effect of alcohol on
increased HDL levels in the low to moderate intake range.53
rs1260326 in GCKR has previously been associated with HDL
levels54 and this was one of the most signiﬁcant associations with
alcohol consumption in the present study. Furthermore, alcohol
PRSs in GS were nominally associated with increased HDL. Our
ﬁndings provide further support for the positive relationship
between alcohol and HDL levels.
A positive genetic correlation was observed between alcohol
consumption and years of schooling and college completion.
Other studies have found an association with educational
Table 2. PRS analyses: PRS for alcohol consumption in Generation
Scotland created using summary statistics of alcohol consumption
GWAS in UKB
Trait (n) β (s.e.) Z ratio r2 P-value
Units per week
(17 461)
0.080 (0.007) 10.10 0.6% 6.5 × 10−24
Ever smoke (19 289) − 0.143 (0.004) − 0.009 0.04% 0.01
BMI (19 771) − 0.024(0.007) − 3.21 0.056% 0.0013
Hips (1958) − 0.009 (0.008) − 1.24 0.009% 0.21
HDL cholesterol
(19 108)
0.03 (0.007) 4.09 0.03% 0.000043
Abbreviations: BMI, body mass index; CHR, chromosome; Freq, A1
frequency; GWAS, genome-wide association study; HDL, high-density
lipoprotein; PRS, polygenic risk score; POS, base pair position; SNP, single-
nucleotide polymorphism; UKB, UK Biobank. Association analyses per-
formed in AS-Reml-R using pedigree information to control for relatedness.
Units per week phenotype for current drinkers only. All models adjusted
for age, sex and four multidimensional scaling (MDS) components to
control for population stratiﬁcation. Bold highlighted P-values are
statistically signiﬁcant after correction for multiple testing (P⩽ 0.01).
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attainment and alcohol consumption. A study of individuals in the
British Cohort Study found that educational attainment was linked
to increased risk of daily alcohol consumption at age 34 years and
that this was stronger in females.55 We also ﬁnd a stronger genetic
correlation with college completion in females compared with
males (rG 0.33 vs 0.10). Another study on the British Cohort Study
found mental ability at age 10 years was linked to increased
alcohol consumption and alcohol problems at age 30 years.56
Childhood academic ability at age 11 years has been positively
correlated with alcohol consumption in early adolescence.57 This
relationship extends into older age as a link between alcohol
consumption and cognitive ability in 70 year olds was observed in
the Lothian Birth Cohort, although after correcting for socio-
economic status and childhood intelligence much of this
association was attenuated.58
Negative genetic correlations were observed for several
anthropometric traits including BMI and obesity, such that genetic
variants that increased risk for alcohol consumption decrease the
risk for overweight phenotypes. As alcohol has a caloric content of
7.1 kcal g− 1, it seems counterintuitive that increased alcohol
consumption negatively correlates with measures of obesity. A
genetic variant in FTO that increases risk for obesity is also
associated with increased risk for alcohol dependence.59 However,
there is some evidence that high alcohol consumers have altered
metabolism. A study of alcohol-dependent individuals found that
those consuming the highest levels of alcohol had increased
metabolism and decreased fat mass and leptin levels.60 Further-
more, high alcohol consumption can impair nutrient absorption.61
The many studies of obesity and alcohol consumption have
indicated a complex relationship62 with reports of both negative
and positive correlations between alcohol and BMI.63,64 We also
report a negative genetic correlation between alcohol consump-
tion and leptin levels (rG =− 0.26, s.e. = 0.08). Leptin is a hormone
generated by adipose cells and is involved in inducing satiety.
Moderate alcohol consumption has been linked to inhibition of
leptin in healthy volunteers65 but a study of healthy postmeno-
pausal women found the ingestion of 15–30 g of alcohol per day
associated with increased serum leptin levels.66 Work in rodents
has shown that alcohol consumption decreases serum leptin but
increases leptin levels in adipose tissue.67 These ﬁndings are
intriguing and the genetic link between hunger, obesity and
alcohol consumption warrants further investigation.
The traits that show a genetic correlation with alcohol
consumption may correlate because of shared genetic effects on
both traits or because of causal pathways between traits. In
addition, genetic confounding may inﬂuence the correlations. A
genetic correlation between smoking and alcohol consumption
was identiﬁed in this study. As smoking also inﬂuences triglyceride
levels68 this may be an indirect cause of the negative genetic
correlation between alcohol consumption and triglyceride levels.
Future studies should use Mendelian randomization analyses with
the genetic variants identiﬁed in this study to probe causal
relationships between alcohol use and health traits. Assortative
mating may also inﬂuence the genetic correlations identiﬁed in
this study. Alcohol consumption and nicotine use have been
shown to be factors for nonrandom mating,69 and it is unclear
what effect, if any, this would have on the genetic correlations
presented in this study.
This investigation has several advantages compared with
previous studies. We studied a single large sample of ancestrally
similar individuals from a relatively narrow age range, all of whom
were residing in the United Kingdom at the time of interview.
Using a sample where all individuals are exposed to similar social
norms is advantageous as cultural inﬂuences are an important
inﬂuence on alcohol intake patterns.70 Furthermore, all data were
subject to the same quality control procedures and these factors
would have contributed to our ability to detect eight independent
genome-wide signiﬁcant loci when similar-sized alcohol
consumption GWAS did not.15 The main limitation of this study
is the reliance on self-reported alcohol consumption and the
reliability of this measure. However, the UKB touchscreen inter-
view used to ascertain alcohol intake used pictures to represent
different drink sizes that may have increased reliability. Finally, the
results presented here may only be applicable to middle- to older-
aged white British individuals. Considering that genetic inﬂuences
on alcohol consumption change across the life course,71 the
variants identiﬁed in this study may have limited relevance
outside of this demographic. It is important to note that the mean
weekly alcohol consumption for males in this sample was 20.8
units per week, almost 6 units higher than the UK Chief Medical
Ofﬁcers’ recommendation of 14 units per week for men and
women. This suggests that among this demographic, males are
regularly consuming levels of alcohol that could cause risks to
health.
This study presents the largest single GWAS of alcohol
consumption to date and identiﬁes eight genetic loci, at least
three of which are novel. The SNP heritability of alcohol
consumption is described for the ﬁrst time with 13% of the
variance in alcohol consumption attributable to genetic factors in
this sample. Many of the genes identiﬁed in this study are
expressed in the liver, suggesting that alcohol metabolism is an
important driver of differences in consumption. Genetic correla-
tion analyses found associations between alcohol consumption
and many positive health and behavioural traits such as higher
education, lower obesity and high HDL cholesterol levels.
Although it is clear that high levels of alcohol consumption are
linked to poorer health outcomes, the positive genetic correlations
identiﬁed in this study are intriguing and warrant further
exploration. Future work should focus on characterizing the
biological role of the newly identiﬁed genetic variants in alcohol
consumption and the potential causal relationships between
alcohol use and health-related traits.
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